Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion type Assertion NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_head.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion description "[Two of 7 (29%) mut+ developed progressive disease and died with a median follow-up time of 22 months; while 13/18 (72%) mut- developed progressive disease and 10/18 (56%) died with median TTP of 12 months and median survival of 14 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_provenance.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion evidence source_evidence_literature NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_provenance.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion SIO_000772 20942962 NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_provenance.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion wasDerivedFrom befree-20140225 NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_provenance.
- NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_assertion wasGeneratedBy ECO_0000203 NP600692.RAtmPKmtJpFmXnUR0Y9oBv2eS1cnGv0axHp83Z814-yt8130_provenance.